Travere Therapeutics (TVTX) Revenue (QoQ) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Travere Therapeutics | 4.34 Bn | 4.26 Bn | 102.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 136.16% |
| Dec 31, 2025 | -979.35% |
| Sep 30, 2025 | -65.05% |
| Jun 30, 2025 | 40.03% |
| Mar 31, 2025 | 9.29% |
| Dec 31, 2024 | 18.90% |
| Sep 30, 2024 | 16.23% |
| Jun 30, 2024 | 30.80% |
| Mar 31, 2024 | -8.18% |
| Dec 31, 2023 | 21.47% |
| Sep 30, 2023 | 15.22% |
| Jun 30, 2023 | 4.23% |
| Mar 31, 2023 | 5.28% |
| Dec 31, 2022 | 4.50% |
| Sep 30, 2022 | -1.95% |
| Jun 30, 2022 | 22.30% |
| Mar 31, 2022 | 114.80% |
| Dec 31, 2021 | -387.71% |
| Sep 30, 2021 | 0.70% |
| Jun 30, 2021 | 15.21% |
| Mar 31, 2021 | -7.01% |
| Dec 31, 2020 | -0.31% |
| Sep 30, 2020 | 5.59% |
| Jun 30, 2020 | 1.38% |
| Mar 31, 2020 | 2.32% |
| Dec 31, 2019 | 5.22% |
| Sep 30, 2019 | -0.75% |
| Jun 30, 2019 | 12.98% |
| Mar 31, 2019 | -9.60% |
| Dec 31, 2018 | 7.53% |
| Sep 30, 2018 | -1.53% |
| Jun 30, 2018 | 7.56% |
| Mar 31, 2018 | -8.88% |
| Dec 31, 2017 | 4.55% |
| Sep 30, 2017 | 3.97% |
| Jun 30, 2017 | 15.41% |
| Mar 31, 2017 | -9.93% |
| Dec 31, 2016 | 9.96% |
| Sep 30, 2016 | 1.90% |
| Jun 30, 2016 | 14.83% |
| Mar 31, 2016 | -4.73% |
| Dec 31, 2015 | 8.72% |
| Sep 30, 2015 | 16.36% |
| Jun 30, 2015 | 38.54% |
| Mar 31, 2015 | 23.34% |
| Dec 31, 2014 | 68.72% |
| Sep 30, 2014 | 45.38% |
| Jun 30, 2014 | 20,407.14% |